ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 46 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $495,000 | -6.6% | 500,000 | 0.0% | 0.06% | -10.0% |
| Q4 2017 | $530,000 | -0.4% | 500,000 | 0.0% | 0.07% | +14.8% |
| Q3 2017 | $532,000 | -0.2% | 500,000 | 0.0% | 0.06% | +7.0% |
| Q2 2017 | $533,000 | +10.4% | 500,000 | 0.0% | 0.06% | +5.6% |
| Q1 2017 | $483,000 | -5.5% | 500,000 | 0.0% | 0.05% | -8.5% |
| Q4 2016 | $511,000 | +9.4% | 500,000 | 0.0% | 0.06% | +7.3% |
| Q3 2016 | $467,000 | – | 500,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 9,821,000 | $11,314,000 | 1.07% |
| TFG Asset Management GP Ltd | 6,000,000 | $6,883,000 | 1.02% |
| Alken Asset Management Ltd | 400,000 | $461,000 | 0.79% |
| Lombard Odier Asset Management (Europe) Ltd | 6,525,000 | $7,470,000 | 0.54% |
| CSS LLC/IL | 8,000,000 | $9,158,000 | 0.51% |
| IRON Financial LLC | 505,000 | $578,000 | 0.28% |
| MACKAY SHIELDS LLC | 32,796,000 | $37,597,000 | 0.26% |
| OSTRUM ASSET MANAGEMENT | 400 | $459,000 | 0.22% |
| RWC Asset Management LLP | 4,400,000 | $5,037,000 | 0.20% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,871,000 | $5,580,000 | 0.16% |